Sandvig-Pharma ApS

CVR 40667687 · Private limited company (ApS) · Active · High risk

Sandvig-Pharma ApS is a Private limited company (ApS), founded on , based in Aabenraa. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 3.4% over the next 12 months, which is 2.4 times the average for Danish companies. 6 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (30 Jun 2025) shows equity of DKK -17.8m and a net result of DKK -4.0m.

Bankruptcy risk for Sandvig-Pharma ApS

3.4%
probability of bankruptcy within 12 months
High risk

2.4 × the average (1.41%) · higher risk than 88% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Auditor's statementNo assurance · bankruptcy rate 13.2%1.5×
Number of CEOs0 · bankruptcy rate 12.7%1.4×
Number of auditors (historical)0 · bankruptcy rate 12.5%1.4×
CEOs in total (historical)0 · bankruptcy rate 12.4%1.4×

Reduces the risk

Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Reporting classReporting class B · bankruptcy rate 5.7%0.65×
RegionSyddanmark · bankruptcy rate 6.0%0.68×
Published annual reports5–10 · bankruptcy rate 6.3%0.72×
Going-concern uncertaintyNo · bankruptcy rate 6.4%0.73×
Industry changes1 · bankruptcy rate 6.5%0.74×
Age (years)5–10 yrs · bankruptcy rate 7.0%0.80×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
40667687
Status
Active
Company type
Private limited company (ApS)
Founded
(7 years)
Address
Kirkeplads 8
6200 Aabenraa
Municipality
Aabenraa
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 50k
Audit opted out
Yes

Warning signs

Annual reports filed late1 of 6
Missing annual reportNo
Negative equityYes
Equity ratio-246.5%
Current ratio25%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address11
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -4.5mDKK -7.0m
Net profitDKK -4.0mDKK -5.6m
EquityDKK -17.8mDKK -13.9m
Total assetsDKK 7.2mDKK 6.3m
CashDKK 8,399–
Short-term debtDKK 25.1m–
Avg. employees2–

Latest annual report: Reporting class B · auditor's statement: No assurance.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jul 2024 – 30 Jun 2025151
1 Jul 2023 – 30 Jun 2024141
1 Jul 2022 – 30 Jun 2023182
1 Jul 2021 – 30 Jun 2022169
1 May 2020 – 30 Apr 202160
12 Jul 2019 – 30 Apr 2020255 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
Owner (100%)Sandvig Capital ApSCurrent
Owner (100%)Gunhild Nyborg Pedersen
Owner (100%)Denker Invest ApS
FounderGunhild Nyborg PedersenCurrent

Address history (1 moves)

Kirkeplads 8, 6200 Aabenraa
Stolligvej 59, 6200 Aabenraa

Former names

Sandvig-Pharma ApS – now
Z-Pharma ApS –
Zibo Pharma ApS –
Universe of Dreams ApS –

Other companies at the same address

Similar companies in Aabenraa

Questions and answers about Sandvig-Pharma ApS

Has Sandvig-Pharma ApS gone bankrupt?

No, Sandvig-Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Sandvig-Pharma ApS?

Our model estimates a bankruptcy risk of 3.4% over the next 12 months (high risk), which is 2.4 times the average for Danish companies.

When was Sandvig-Pharma ApS founded?

Sandvig-Pharma ApS was founded on 12 July 2019.

What is the equity of Sandvig-Pharma ApS?

Equity was DKK -17.8m according to the annual report for the period ending 30 June 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.